[ Network menu | Network entry | Help ]

ENTRY	nt06227
Name	Nuclear receptor signaling (cancer)
Category	Disease view; Cancer signaling
Display	drug-target relation   disease type

N00083    (T,DHT) → AR ⇒ KLK3 N00084    (T,DHT) → AR* ⇒ KLK3 N00085    (T,DHT,E2,P4,FLUT,.. → AR* ⇒ KLK3       D1  |     N00286    E2 → ((ESR1/2)+(NCOA1/2.. ⇒ (BCL2,EBAG9,KRT19,.. N00287    E2 → (ESR*+(NCOA3,NCOA1.. ⇒ (CCND1,MYC)       D1  |     N01364    E2 → ESR1/2 ⇒ (EGF,FGF9,DLL) N01362    P4 → PGR ⇒ (CCND1,TNFSF11,WNT.. N01363    (P4,MPA) → PGR ⇒ (WNT1,NOTCH2,JAG1)   N00317    KA → (AHR+ARNT) ⇒ (IL6,IL22,PTGS2,VE.. N01365    TCDD → (AHR+ARNT) ⇒ (CYP1A1,CYP1B1,GST.. N01366    BaP → (AHR+ARNT) ⇒ (CYP1A1,CYP1B1) N01367    PCB → (AHR+ARNT) ⇒ (CYP1A1,CYP1B1) N01368    HCB → (AHR+ARNT) ⇒ CYP1A1

		Drug name
D1	D12217	Imlunestrant tosylate (USAN)